Correlation Between Citius Pharmaceuticals and Galera Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Citius Pharmaceuticals and Galera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citius Pharmaceuticals and Galera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citius Pharmaceuticals and Galera Therapeutics, you can compare the effects of market volatilities on Citius Pharmaceuticals and Galera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citius Pharmaceuticals with a short position of Galera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citius Pharmaceuticals and Galera Therapeutics.

Diversification Opportunities for Citius Pharmaceuticals and Galera Therapeutics

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between Citius and Galera is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Citius Pharmaceuticals and Galera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galera Therapeutics and Citius Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citius Pharmaceuticals are associated (or correlated) with Galera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galera Therapeutics has no effect on the direction of Citius Pharmaceuticals i.e., Citius Pharmaceuticals and Galera Therapeutics go up and down completely randomly.

Pair Corralation between Citius Pharmaceuticals and Galera Therapeutics

If you would invest  258.00  in Galera Therapeutics on August 31, 2024 and sell it today you would earn a total of  0.00  from holding Galera Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy4.55%
ValuesDaily Returns

Citius Pharmaceuticals  vs.  Galera Therapeutics

 Performance 
       Timeline  
Citius Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Citius Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Galera Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Galera Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Galera Therapeutics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Citius Pharmaceuticals and Galera Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Citius Pharmaceuticals and Galera Therapeutics

The main advantage of trading using opposite Citius Pharmaceuticals and Galera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citius Pharmaceuticals position performs unexpectedly, Galera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galera Therapeutics will offset losses from the drop in Galera Therapeutics' long position.
The idea behind Citius Pharmaceuticals and Galera Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years